Prof. Dr. Melike ÖZÇELİK

1. Prognostic significance of neuroendocrine differentiation and PD-L1 expression in treatment-naïve prostate cancer

Tosun I., Sahin O., Bakkaloğlu İ. G., Şişik N. M., Özçelik M.

BMC Urology , cilt.26, sa.1, 2026 (SCI-Expanded, Scopus)

2. Mismatch Repair Deficiency and Programmed Death-Ligand 1 Expression in Treatment-Naïve High-Risk and Very High-Risk Locally Advanced Prostate Cancer: Histomorphological Associations and Prognostic Value

Sahin O., Tosun İ., Küçük E. V., Eser M., Özçelik M., Zemheri I. E.

International Journal of Surgical Pathology , cilt.34, sa.6, ss.1468-1482, 2026 (SCI-Expanded, Scopus)

3. The Role of Diagnostic Laparoscopy in Staging and Treatment Planning of Gastric Cancer: A 400-Patient Retrospective Cohort Study

Gunes Capar T. K., Ozcan P., Savas M. M., DÜZGÜN Ö., Ozcelik M.

Diagnostics , cilt.16, sa.16, 2026 (SCI-Expanded, Scopus)

4. Next-Generation Sequencing-Based Detection of KRAS G12D Variants in Colorectal Cancer: A Retrospective Cohort Study

HEKİMOĞLU G., Eser M., Yarar M. H., Ayranci F. G., Ozcelik M.

Genes , cilt.17, sa.2, 2026 (SCI-Expanded, Scopus)

5. Chronic kidney disease and denosumab in metastatic bone disease: A multicenter Turkish cohort study on severe hypocalcemia, skeletal events, and survival

Ellez H. İ., SEMİZ H. S., EKİNCİ F., ERDOĞAN A. P., Kuş F., Karataş F., et al.

Journal of Bone Oncology , cilt.55, 2025 (SCI-Expanded, Scopus)

6. The impact of carboplatin on pathologic complete response and survival based on HER2 low and HER2 zero status in triple negative breast cancer patients receiving neoadjuvant chemotherapy: a multicenter real-world analysis

Yıldırım S., Başoğlu T., Doğan A., Akdağ G., Kınıkoğlu O., Topal A., et al.

BMC Cancer , cilt.25, sa.1, 2025 (SCI-Expanded, Scopus)

7. Analysis of Molecular Differences in Metastatic Colorectal Cancers and Their Impact on Prognosis Metastatik Kolorektal Kanserlerde Moleküler Farklılıkların Analizi ve Prognostik Sonuçları

ÖZKAN Ö. F., Yıldırak M. K., Ülgür H. Ş., Kırkan E. F., Kızıltoprak N., Karakullukçu H. K., et al.

Medical Journal of Bakirkoy , cilt.21, sa.1, ss.24-30, 2025 (ESCI, Scopus, TRDizin) Sürdürülebilir Kalkınma

8. Comparing the efficacy of regorafenib and 5-fluorouracil-based rechallenge chemotherapy in the third-line treatment of metastatic colorectal cancer

Taşçı E. Ş., Oyan B., Sönmez Ö., Mutlu A. U., Atcı M. M., Sakin A., et al.

BMC Cancer , cilt.24, sa.1, 2024 (SCI-Expanded, Scopus)

9. KRAS G12C mutation in NSCLC in a small genetic center: insights into sotorasib therapy response potential

Eser M., HEKİMOĞLU G., Yarar M. H., Canbek S., ÖZÇELİK M.

Scientific Reports , cilt.14, sa.1, 2024 (SCI-Expanded, Scopus)

10. The Effectiveness of Adjuvant PD-1 Inhibitors in Patients with Surgically Resected Stage III/IV Acral Melanoma

Arak H., Erkiliç S., Yaslikaya Ş., Eylemer Mocan E., Aktaş G., Özdemir M., et al.

Journal of Immunotherapy , cilt.47, sa.5, ss.182-189, 2024 (SCI-Expanded, Scopus)

11. The Prognostic Utility of the Metastatic Lymph Node Ratio and the Number of Regional Lymph Nodes Removed from Patients with Small Bowel Adenocarcinomas

Aydin D., KEFELİ U., ÖZÇELİK M., ERDEM G. U., Sendur M. A., Yildirim M. E., et al.

Medicina (Lithuania) , cilt.59, sa.8, 2023 (SCI-Expanded, Scopus)

12. Does Proton Pump Inhibitors Decrease the Efficacy of Palbociclib and Ribociclib in Patients with Metastatic Breast Cancer?

ODABAŞ H., Dogan A., ÖZÇELİK M., Yildirim S., Ozkerim U., TURAN N., et al.

Medicina (Lithuania) , cilt.59, sa.3, 2023 (SCI-Expanded, Scopus)

13. An exceptionally rare case of metastatic high-grade urothelial carcinoma of the renal pelvis to the pancreas diagnosed on endoscopic ultrasound-guided fine-needle aspiration: A diagnostic challenge

Koyuncuer A., Sayar S., Zemheri I. E., Özdil K., ÖZÇELİK M.

Diagnostic Cytopathology , cilt.50, sa.10, 2022 (SCI-Expanded, Scopus)

14. Efficacy and safety profile of COVID-19 vaccine in cancer patients: A prospective, multicenter cohort study

Yasin A. I., AYDIN S., SÜMBÜL B., KORAL L., Simşek M., Geredeli Ç., et al.

Future Oncology , cilt.18, sa.10, ss.1235-1244, 2022 (SCI-Expanded, Scopus)

15. Side effects of immune-checkpoint inhibitors: Can multiple side effects be seen in a patient?

Özyurt E., Özçelik S., Sürmeli H., ÇELİK M., Ayhan M., Özçelik M.

Journal of Oncology Pharmacy Practice , cilt.28, sa.2, ss.462-465, 2022 (SCI-Expanded, Scopus)

16. Efficacy and safety of trastuzumab emtansine in older patients with HER2-positive advanced breast cancer: a real-world study

Cil I., KÜÇÜKARDA A., Atcı M. M., Secmeler S., Paksoy N., Ferhatoglu F., et al.

Tumori , cilt.108, sa.1, ss.19-25, 2022 (SCI-Expanded, Scopus)

17. Cytoreductive surgery versus systemic chemotherapy alone in isolated peritoneal carcinomatosis of colorectal origin

ÖZÇELİK M., Oyman A., Cil I., DÜZGÜN Ö., ÖZKAN Ö. F., Ayhan M.

Journal of the College of Physicians and Surgeons Pakistan , cilt.31, sa.11, ss.1308-1313, 2021 (SCI-Expanded, Scopus)

18. Efficacy of abiraterone acetate in castration-resistant metastatic prostate cancer: A real-world data analysis

OYMAN A., Başak M., ÖZÇELİK M., Özyükseler D. T., Işık S., Yıldırım M. E.

Asia-Pacific Journal of Clinical Oncology , cilt.17, sa.5, 2021 (SCI-Expanded, Scopus)

19. Association of illness perception with chemotherapy-induced nausea and vomiting: A Turkish Oncology Group (TOG) study

Kus T., Aktas G., ÖZÇELİK M., Dirikoc M., Sakalar T., Oyman A., et al.

Future Oncology , cilt.17, sa.15, ss.1933-1942, 2021 (SCI-Expanded, Scopus)

20. Pazopanib for metastatic soft-tissue sarcoma: A multicenter retrospective study

Koca S., Beşiroğlu M., ÖZÇELİK M., Karaca M., BİLİCİ M., HACIOĞLU M. B., et al.

Journal of Oncology Pharmacy Practice , cilt.27, sa.3, ss.541-546, 2021 (SCI-Expanded, Scopus)

21. Germline pathogenic variant spectrum in 25 cancer susceptibility genes in Turkish breast and colorectal cancer patients and elderly controls

Akçay İ. M., Celik E., Agaoglu N. B., Alkurt G., Kizilboga Akgun T., Yildiz J., et al.

International Journal of Cancer , cilt.148, sa.2, ss.285-295, 2021 (SCI-Expanded, Scopus)

22. Prognostic factors in resected biliary tract cancers and the impact of cytokeratin 20 expression

Çil İ., Oyman A., Işik S., Ayhan M., Ökten İ. N., Yilmaz M., et al.

Journal of Oncological Science , cilt.7, sa.3, ss.125-132, 2021 (Scopus, TRDizin)

23. Role of testosterone to estradiol ratio in predicting the efficacy of recombinant human chorionic gonadotropin and testosterone treatment in male hypogonadism

ÇELİK M., Özçelik S., BAŞ S., Sariaydin M., ÖZÇELİK M., Gozu H.

Archives of Endocrinology and Metabolism , cilt.65, sa.5, ss.617-624, 2021 (SCI-Expanded, Scopus)

24. Outcomes of transition from premixed and intensive insulin therapies to insulin aspart/degludec co-formulation in type 2 diabetes mellitus: A real-world experience

Özçelik S., ÇELİK M., Vural A., Bünyamin Aydin A., ÖZÇELİK M., Gozu H.

Archives of Medical Science , cilt.17, sa.1, ss.1-8, 2021 (SCI-Expanded, Scopus)

25. PTK-7 expression in gastric cancer: A prognostic determinant

ÖZÇELİK M., Ercelep Ö., Keser S., Barışık N. Ö., Başar M., ODABAŞ H., et al.

Balkan Medical Journal , cilt.37, sa.2, ss.91-97, 2020 (SCI-Expanded, Scopus, TRDizin)

26. Efficacy of insulin, heparin and fenofibrate combination treatment in severe hypertriglyceridemia: Double center experience

Ozcelik S., BAŞ S., ÖZÇELİK M., Sarıaydın M., ÇELİK M., Gözü H.

Acta Endocrinologica , cilt.15, sa.4, ss.460-465, 2019 (SCI-Expanded, Scopus)